1.
External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients
2.
3.
4.
5.
6.
7.
8.
9.
Improving screening mammography in the south of the Netherlands: Using an extended data collection on diagnostic procedures and outcome parameters
No increased risk for cervical cancer after a broader definition of a negative pap smear
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial:...
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthra...
Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project
Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy
Occupational asbestos exposure: how to deal with suspected mesothelioma cases--the Dutch approach
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial